Orbimed Advisors - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 1 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$15,032,000
-24.8%
275,000
-41.4%
0.13%
-33.0%
Q4 2014$19,989,000
+296.4%
469,000
+196.8%
0.19%
+260.4%
Q3 2014$5,042,000158,0000.05%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 4,060,000$46,893,0003.11%
Camber Capital Management LP 4,390,000$50,705,0002.67%
Palo Alto Investors LP 3,078,874$35,561,0002.37%
Permanens Capital L.P. 407,811$4,710,0001.32%
Fondren Management LP 35,000$404,0000.34%
IRONWOOD INVESTMENT MANAGEMENT LLC 33,524$387,0000.29%
BOOTHBAY FUND MANAGEMENT, LLC 240,000$2,772,0000.25%
Broadfin Capital, LLC 100,000$1,155,0000.21%
FOX RUN MANAGEMENT, L.L.C. 13,687$158,0000.14%
Spark Investment Management LLC 92,200$1,064,0000.14%
View complete list of AMAG PHARMACEUTICALS INC shareholders